Corporate Banner
Satellite Banner
Technology Networks Header
Thursday, December 18, 2014
Technology Networks
 
Register | Sign in
Home Page>Latest Webcasts

  Webcasts

Scientific News
Novel Agent Decreases Neuropathic Pain in Patients with Type 2 Diabetes
Promising profile of disease modification and pain reduction leads to proof of concept trials.
Barrier-Breaking Drug May Lead to Spinal Cord Injury Treatments
NIH-funded scientists take first step towards developing promising new drug.
Two Drugs are No More Effective Than One to Treat Common Kidney Disease
NIH study finds limited kidney benefit from more rigorous blood pressure treatment.
Antibiotic Resistance Threatens Future of Modern Medicine
Overuse and misuse of antibiotics, one of the key contributors to antimicrobial resistance (AMR).
Computer Model Sets New Precedent in Drug Discovery
New computational model can precisely simulate, predict therapeutic protein behaviors to help zero in on ideal drug design candidates.
New Drug for Common Liver Disease Improves Liver Health
An experimental drug aimed at treating a common liver disease showed promising results and potential problems in a multicenter clinical trial funded by the NIH.
'Rewriting' the Way to Make Natural Drug Compounds
Using an organism's own pathway to synthesize potential therapeutics.
MS Drug Candidate Shows Promise for Ulcerative Colitis
Positive new clinical data were released today on a drug candidate for ulcerative colitis that was first discovered and synthesized at The Scripps Research Institute.
New Technique has Profound Implications for Drug Development
The method, developed by Scripps Research Institute chemists, expands options for making pure batches of ‘one-handed’ molecules.
Team Discovers How Microbes Build a Powerful Antibiotic
Researchers discovery opens up new avenues of research into thousands of similar molecules.

US Patent Law of 2011 the Good the Bad and the Expensive
Thomas Saunders, Rissman Hendricks & Oliverio, speaking at Drug Chemistry Congress 2012.

Strategic Applications of Flow Chemistry within Drug Discovery
Paul Richardson, Synthesis Group Leader, Pfizer, speaking at Flow Chemistry Congress.

Protecting IP in Chemistry Outsourcing
Hiroshi Sheraton, McDermott Will & Emery, speaking at Discovery Chemistry Congress 2012.

Outsourcing in Discovery Chemistry Strategy Selection Success
Hansjoerg Lehmann, Novartis Pharma AG, speaking at Discovery Chemistry Congress 2012.

Outsourcing Chemical Synthesis in the Drug Discovery Process
Gunter Festel, Autodisplay Biotech, speaking at Discovery Chemistry Congress 2012

The Potassium Channels Kv1.3 and KCa3.1 as Targets for Inflammatory Brain Pathologies
Professor Heike Wulff, University of California, speaking at Ion Channel Targets 2011.

Alpha2* Nicotinic Acetylcholine Receptors as a Therapeutic Target for Memory Enhancement
Dr Katumi Sumikawa, University of California, speaking at Ion Channel Targets 2011.

Smooth Muscle Kv7 (KCNQ) Potassium Channels: Important New Therapeutic Targets
Professor Kenneth Byron, Loyola University Chigaco, speaking at Ion Channel Targets 2011.

Protons, Heat and Mechanical Force Converge to Gate Two-Pore Potassium Channels at the Selectivity Filter
Dr Slav Bagriantsev, University of California, speaking at Ion Channel Targets 2011.

<< 1 2 3 4 5 6 7 >>
Showing Results 21 - 30 of 134
Skyscraper Banner
SELECTBIO Market Reports
LabTube - Videos for the Scientific Community
eposters - The Online Journal of Scientific Posters
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn